170 related articles for article (PubMed ID: 28094268)
21. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.
Li R; Chen X; You Y; Wang X; Liu Y; Hu Q; Yan W
Oncotarget; 2015 Oct; 6(31):30968-74. PubMed ID: 26427041
[TBL] [Abstract][Full Text] [Related]
23. Glioblastoma cells deficient in DNA-dependent protein kinase are resistant to cell death.
Chen GG; Sin FL; Leung BC; Ng HK; Poon WS
J Cell Physiol; 2005 Apr; 203(1):127-32. PubMed ID: 15493013
[TBL] [Abstract][Full Text] [Related]
24. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.
Albertoni M; Shaw PH; Nozaki M; Godard S; Tenan M; Hamou MF; Fairlie DW; Breit SN; Paralkar VM; de Tribolet N; Van Meir EG; Hegi ME
Oncogene; 2002 Jun; 21(27):4212-9. PubMed ID: 12082608
[TBL] [Abstract][Full Text] [Related]
25. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
26. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.
Lin H; Xiong W; Zhang X; Liu B; Zhang W; Zhang Y; Cheng J; Huang H
Oncol Rep; 2011 Oct; 26(4):925-30. PubMed ID: 21743969
[TBL] [Abstract][Full Text] [Related]
27. Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status.
Djuzenova CS; Fiedler V; Memmel S; Katzer A; Hartmann S; Krohne G; Zimmermann H; Scholz CJ; Polat B; Flentje M; Sukhorukov VL
Exp Cell Res; 2015 Jan; 330(2):346-357. PubMed ID: 25149900
[TBL] [Abstract][Full Text] [Related]
28. ATM-mediated PTEN phosphorylation promotes PTEN nuclear translocation and autophagy in response to DNA-damaging agents in cancer cells.
Chen JH; Zhang P; Chen WD; Li DD; Wu XQ; Deng R; Jiao L; Li X; Ji J; Feng GK; Zeng YX; Jiang JW; Zhu XF
Autophagy; 2015; 11(2):239-52. PubMed ID: 25701194
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Nucleotide Synthesis Targets Brain Tumor Stem Cells in a Subset of Glioblastoma.
Laks DR; Ta L; Crisman TJ; Gao F; Coppola G; Radu CG; Nathanson DA; Kornblum HI
Mol Cancer Ther; 2016 Jun; 15(6):1271-8. PubMed ID: 27196770
[TBL] [Abstract][Full Text] [Related]
30. PTEN is destabilized by phosphorylation on Thr366.
Maccario H; Perera NM; Davidson L; Downes CP; Leslie NR
Biochem J; 2007 Aug; 405(3):439-44. PubMed ID: 17444818
[TBL] [Abstract][Full Text] [Related]
31. MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis.
Sato A; Sunayama J; Matsuda K; Seino S; Suzuki K; Watanabe E; Tachibana K; Tomiyama A; Kayama T; Kitanaka C
Stem Cells; 2011 Dec; 29(12):1942-51. PubMed ID: 21957016
[TBL] [Abstract][Full Text] [Related]
32. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway.
Xia X; Li Y; Wang W; Tang F; Tan J; Sun L; Li Q; Sun L; Tang B; He S
Mol Cancer; 2015 Aug; 14():154. PubMed ID: 26265437
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of DNA double strand break repair and chromosome aberration formation.
Iliakis G; Wang H; Perrault AR; Boecker W; Rosidi B; Windhofer F; Wu W; Guan J; Terzoudi G; Pantelias G
Cytogenet Genome Res; 2004; 104(1-4):14-20. PubMed ID: 15162010
[TBL] [Abstract][Full Text] [Related]
35. Casein kinase II phosphorylates the C-terminal region of Lif1 to promote the Lif1-Xrs2 interaction needed for non-homologous end joining.
Matsuzaki K; Shinohara M
Biochem Biophys Res Commun; 2018 Jul; 501(4):1080-1084. PubMed ID: 29778533
[TBL] [Abstract][Full Text] [Related]
36. Loss of tumour suppressor PTEN expression in renal injury initiates SMAD3- and p53-dependent fibrotic responses.
Samarakoon R; Helo S; Dobberfuhl AD; Khakoo NS; Falke L; Overstreet JM; Goldschmeding R; Higgins PJ
J Pathol; 2015 Aug; 236(4):421-32. PubMed ID: 25810340
[TBL] [Abstract][Full Text] [Related]
37. JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.
Xu W; Chen Q; Wang Q; Sun Y; Wang S; Li A; Xu S; Røe OD; Wang M; Zhang R; Yang L; Zhou J
Cell Death Dis; 2014 Dec; 5(12):e1551. PubMed ID: 25476899
[TBL] [Abstract][Full Text] [Related]
38. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
Chen Z; Trotman LC; Shaffer D; Lin HK; Dotan ZA; Niki M; Koutcher JA; Scher HI; Ludwig T; Gerald W; Cordon-Cardo C; Pandolfi PP
Nature; 2005 Aug; 436(7051):725-30. PubMed ID: 16079851
[TBL] [Abstract][Full Text] [Related]
39. Pediatric glioblastomas: a histopathological and molecular genetic study.
Suri V; Das P; Pathak P; Jain A; Sharma MC; Borkar SA; Suri A; Gupta D; Sarkar C
Neuro Oncol; 2009 Jun; 11(3):274-80. PubMed ID: 18981259
[TBL] [Abstract][Full Text] [Related]
40. Pathology: commonly monitored glioblastoma markers: EFGR, EGFRvIII, PTEN, and MGMT.
Camara-Quintana JQ; Nitta RT; Li G
Neurosurg Clin N Am; 2012 Apr; 23(2):237-46, viii. PubMed ID: 22440867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
